Cabotegravir

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 783 publications

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.

Journal: Antimicrobial agents and chemotherapy

Published: April 15, 2026

Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failure.

Successful initiation of fully parenteral antiretroviral therapy in a treatment-naïve person with HIV-1 infection and intestinal failure.

Journal: HIV research & clinical practice

Published: April 11, 2026

Lenacapavir as pre-exposure prophylaxis for HIV prevention.

Lenacapavir as pre-exposure prophylaxis for HIV prevention.

Journal: The Cochrane database of systematic reviews

Published: April 01, 2026

Cabotegravir-Loaded Polymeric Micelles: A Promising Strategy for Improved Solubility and Therapeutic Outcomes.

Cabotegravir-Loaded Polymeric Micelles: A Promising Strategy for Improved Solubility and Therapeutic Outcomes.

Journal: Drug development and industrial pharmacy

Published: March 24, 2026

Understanding the clinical implications of the barrier against resistance in antiretroviral treatment.

Understanding the clinical implications of the barrier against resistance in antiretroviral treatment.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 13, 2026

Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness.

Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness.

Journal: Clinical microbiology reviews

Published: March 12, 2026

Optimizing HBV Prevention When Switching to Long-Acting Cabotegravir/Rilpivirine.

Optimizing HBV Prevention When Switching to Long-Acting Cabotegravir/Rilpivirine.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 11, 2026

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025.

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 27, 2026

Health Worker Experiences and Perspectives on the Integration of Long-Acting Injectable Antiretroviral Therapy into a Safety-Net HIV Clinic in the Southeastern United States.

Health Worker Experiences and Perspectives on the Integration of Long-Acting Injectable Antiretroviral Therapy into a Safety-Net HIV Clinic in the Southeastern United States.

Journal: Journal of the International Association of Providers of AIDS Care

Published: February 24, 2026

Severe hyperglycemia after initiation of long-acting cabotegravir in two antiretroviral treatment-controlled people with HIV.

Severe hyperglycemia after initiation of long-acting cabotegravir in two antiretroviral treatment-controlled people with HIV.

Journal: Diabetes & metabolism

Published: February 23, 2026

Bridging the Gap: The PrEP Cascade Paradigm Shift for Long-Acting Injectable HIV Prevention.

Bridging the Gap: The PrEP Cascade Paradigm Shift for Long-Acting Injectable HIV Prevention.

Journal: Viruses

Published: February 22, 2026

Correction to: Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.

Correction to: Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.

Journal: Open forum infectious diseases

Published: February 20, 2026

Showing 1-12 of 783

Last Updated: 04/28/2026